Join
Live feed
·
PRReleasevia Quantisnow
Gilead Sciences Inc. logo
Arcus Biosciences Inc. logo

Gilead Exercises Options to Three Arcus Biosciences Clinical-stage Programs and Adds Research Collaboration

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GILD (Gilead Sciences Inc.), RCUS (Arcus Biosciences Inc.) and more on Quantisnow.